Dysmetabolic iron overload syndrome (DIOS)
Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased tr...
Gespeichert in:
Veröffentlicht in: | La Presse médicale (1983) 2017-12, Vol.46 (12), p.e306-e311 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e311 |
---|---|
container_issue | 12 |
container_start_page | e306 |
container_title | La Presse médicale (1983) |
container_volume | 46 |
creator | Deugnier, Yves Bardou-Jacquet, Édouard Lainé, Fabrice |
description | Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary. |
doi_str_mv | 10.1016/j.lpm.2017.05.036 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1968445979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S075549821730458X</els_id><sourcerecordid>1968445979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-8fdbafac97fe25b9848f2cdbb93b5ee77a7813e2c829c116b70221b674b9328e3</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotlZ_gBuZZRVmTDKPJLiS1keh0IW6DknmDqTMTGoyLfTfm9Lq0tXdfOdw7ofQLcEZwaR6XGftpssoJizDZYbz6gyNKSV5iimrztEYs7JMC8HpCF2FsMaYkoKJSzSiglSCETxGD_N96GBQ2rXWJNa7PnE78K1TdRL2fe1dB8l0vlh93F-ji0a1AW5Od4K-Xl8-Z-_pcvW2mD0vU1PQfEh5U2vVKCNYA7TUghe8oabWWuS6BGBMMU5yoIZTYQipNMNxs65YEQnKIZ-g6bF34933FsIgOxsMtK3qwW2DJKLiRVEKJiJKjqjxLgQPjdx42ym_lwTLgyK5llGRPCiSuJRRUczcneq3uoP6L_HrJAJPRwDikzsLXgZjoTdQWw9mkLWz_9T_APatdWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1968445979</pqid></control><display><type>article</type><title>Dysmetabolic iron overload syndrome (DIOS)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Deugnier, Yves ; Bardou-Jacquet, Édouard ; Lainé, Fabrice</creator><creatorcontrib>Deugnier, Yves ; Bardou-Jacquet, Édouard ; Lainé, Fabrice</creatorcontrib><description>Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.</description><identifier>ISSN: 0755-4982</identifier><identifier>EISSN: 2213-0276</identifier><identifier>DOI: 10.1016/j.lpm.2017.05.036</identifier><identifier>PMID: 29169710</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Humans ; Iron Overload - complications ; Iron Overload - diagnosis ; Iron Overload - physiopathology ; Iron Overload - therapy ; Metabolic Syndrome - complications ; Metabolic Syndrome - diagnosis ; Metabolic Syndrome - physiopathology ; Metabolic Syndrome - therapy</subject><ispartof>La Presse médicale (1983), 2017-12, Vol.46 (12), p.e306-e311</ispartof><rights>2017 Elsevier Masson SAS</rights><rights>Copyright © 2017 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-8fdbafac97fe25b9848f2cdbb93b5ee77a7813e2c829c116b70221b674b9328e3</citedby><cites>FETCH-LOGICAL-c423t-8fdbafac97fe25b9848f2cdbb93b5ee77a7813e2c829c116b70221b674b9328e3</cites><orcidid>0000-0002-2796-2571</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lpm.2017.05.036$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29169710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deugnier, Yves</creatorcontrib><creatorcontrib>Bardou-Jacquet, Édouard</creatorcontrib><creatorcontrib>Lainé, Fabrice</creatorcontrib><title>Dysmetabolic iron overload syndrome (DIOS)</title><title>La Presse médicale (1983)</title><addtitle>Presse Med</addtitle><description>Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.</description><subject>Humans</subject><subject>Iron Overload - complications</subject><subject>Iron Overload - diagnosis</subject><subject>Iron Overload - physiopathology</subject><subject>Iron Overload - therapy</subject><subject>Metabolic Syndrome - complications</subject><subject>Metabolic Syndrome - diagnosis</subject><subject>Metabolic Syndrome - physiopathology</subject><subject>Metabolic Syndrome - therapy</subject><issn>0755-4982</issn><issn>2213-0276</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEUhYMotlZ_gBuZZRVmTDKPJLiS1keh0IW6DknmDqTMTGoyLfTfm9Lq0tXdfOdw7ofQLcEZwaR6XGftpssoJizDZYbz6gyNKSV5iimrztEYs7JMC8HpCF2FsMaYkoKJSzSiglSCETxGD_N96GBQ2rXWJNa7PnE78K1TdRL2fe1dB8l0vlh93F-ji0a1AW5Od4K-Xl8-Z-_pcvW2mD0vU1PQfEh5U2vVKCNYA7TUghe8oabWWuS6BGBMMU5yoIZTYQipNMNxs65YEQnKIZ-g6bF34933FsIgOxsMtK3qwW2DJKLiRVEKJiJKjqjxLgQPjdx42ym_lwTLgyK5llGRPCiSuJRRUczcneq3uoP6L_HrJAJPRwDikzsLXgZjoTdQWw9mkLWz_9T_APatdWQ</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Deugnier, Yves</creator><creator>Bardou-Jacquet, Édouard</creator><creator>Lainé, Fabrice</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2796-2571</orcidid></search><sort><creationdate>201712</creationdate><title>Dysmetabolic iron overload syndrome (DIOS)</title><author>Deugnier, Yves ; Bardou-Jacquet, Édouard ; Lainé, Fabrice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-8fdbafac97fe25b9848f2cdbb93b5ee77a7813e2c829c116b70221b674b9328e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Humans</topic><topic>Iron Overload - complications</topic><topic>Iron Overload - diagnosis</topic><topic>Iron Overload - physiopathology</topic><topic>Iron Overload - therapy</topic><topic>Metabolic Syndrome - complications</topic><topic>Metabolic Syndrome - diagnosis</topic><topic>Metabolic Syndrome - physiopathology</topic><topic>Metabolic Syndrome - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deugnier, Yves</creatorcontrib><creatorcontrib>Bardou-Jacquet, Édouard</creatorcontrib><creatorcontrib>Lainé, Fabrice</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>La Presse médicale (1983)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deugnier, Yves</au><au>Bardou-Jacquet, Édouard</au><au>Lainé, Fabrice</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dysmetabolic iron overload syndrome (DIOS)</atitle><jtitle>La Presse médicale (1983)</jtitle><addtitle>Presse Med</addtitle><date>2017-12</date><risdate>2017</risdate><volume>46</volume><issue>12</issue><spage>e306</spage><epage>e311</epage><pages>e306-e311</pages><issn>0755-4982</issn><eissn>2213-0276</eissn><abstract>Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>29169710</pmid><doi>10.1016/j.lpm.2017.05.036</doi><orcidid>https://orcid.org/0000-0002-2796-2571</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0755-4982 |
ispartof | La Presse médicale (1983), 2017-12, Vol.46 (12), p.e306-e311 |
issn | 0755-4982 2213-0276 |
language | eng |
recordid | cdi_proquest_miscellaneous_1968445979 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Humans Iron Overload - complications Iron Overload - diagnosis Iron Overload - physiopathology Iron Overload - therapy Metabolic Syndrome - complications Metabolic Syndrome - diagnosis Metabolic Syndrome - physiopathology Metabolic Syndrome - therapy |
title | Dysmetabolic iron overload syndrome (DIOS) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A07%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dysmetabolic%20iron%20overload%20syndrome%20(DIOS)&rft.jtitle=La%20Presse%20m%C3%A9dicale%20(1983)&rft.au=Deugnier,%20Yves&rft.date=2017-12&rft.volume=46&rft.issue=12&rft.spage=e306&rft.epage=e311&rft.pages=e306-e311&rft.issn=0755-4982&rft.eissn=2213-0276&rft_id=info:doi/10.1016/j.lpm.2017.05.036&rft_dat=%3Cproquest_cross%3E1968445979%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1968445979&rft_id=info:pmid/29169710&rft_els_id=S075549821730458X&rfr_iscdi=true |